AFP and hepatocellular carcinoma: ROC analysis indicated that the combined detection of serum exosomal miR-34a and AFP has high diagnostic capability in distinguishing HCC patients from healthy controls [188], indicating its promise as a non-invasive biomarker for early detection of HCC and monitoring of metastasis.